Raise Awareness About the National Epidemic of Opioid Misuse, Need Alternative Pain Management
Join us in helping to raise awareness on Opioid Misuse Prevention Day, August 30, 2020.
NeuroOne Medical Technologies Corporation is pleased to play a part in raising awareness for a major epidemic that has ravaged the United States over the past two decades: prescription opioid drug abuse.
Since 1999, the quantity of prescription painkillers prescribed and sold in the U.S. has nearly quadrupled, with a parallel increase of people becoming addicted to narcotics.
Opioids, which include oxycodone, hydrocodone, Percocet, methadone and codeine, are the most abused medications because, in part, many people believe any drug prescribed by a physician is safe. But these drugs can be highly addictive.
Tracing Over-Prescription to Lower Back Pain
During their lives, 80 percent of adults experience lower back pain, which is the second most common reason that adults see a doctor and the most common reason for disability. It’s also one of the most common reasons for an opioid prescription, despite a lack of evidence showing that opioids are effective at treating this problem.
Up to 40% of patients have experienced continued pain after surgery, which is often referred to as Failed Back Surgery Syndrome (FBSS)--persistent or recurrent symptoms in anybody who has had previous spinal surgery.
Neurostimulators—the purposeful modulation of the nervous system's activity using invasive or non-invasive means—represent a growing solution for treating FBSS and back pain.
Targeting Chronic Pain
On Opioid Misuse Prevention Day, we’d also like to spotlight NeuroOne’s mission to provide solutions to treat back pain. We are developing high-definition, minimally invasive thin-film electrodes for the diagnosis and treatment of various neurological conditions, including epilepsy, Parkinson’s disease and chronic pain due to failed back surgeries.
We are also developing an electrode that could be placed percutaneously, much like an epidural injection, and envision temporarily implanting an electrode to determine whether the electrical stimulation improves the patient’s pain. Should the device prove effective after a seven-day trial period, the external power source can be permanently implanted, without the need to remove and re-implant another electrode.
Join us in supporting all physician and medical organizations that are bringing wider attention to the nation’s opioid crisis and helping raise awareness about the causes, dangers and treatments related to opioid abuse and addiction. As part of this discussion, professionals are urged to explore drug-free treatment options that effectively deliver pain relief.
To learn more about NeuroOne, contact us.